Whenever patients are considering peptide therapy, we encourage them to focus on both potential benefits and potential risks
Even so, GLP-1s are forcing scientists to rethink what a single drug can do
Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study
For trainers, we also share how you can provide clients with the best nutritional advice related to vitamin B12 and weight loss
Oral administration of US FDA approved DPP-4 inhibitors, such as Saxagliptin, Vildagliptin, Anagliptin, etc., prolongs the half-lives and thus the action of GLP-1 and GIP, which in turn improves glycemic control with minimal risk of hypoglycemia (Havale and Pal, 2009)